These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26394723)

  • 1. Conformational Flexibility in the Transmembrane Protein TSPO.
    Jaremko Ł; Jaremko M; Giller K; Becker S; Zweckstetter M
    Chemistry; 2015 Nov; 21(46):16555-63. PubMed ID: 26394723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand.
    Jaremko L; Jaremko M; Giller K; Becker S; Zweckstetter M
    Science; 2014 Mar; 343(6177):1363-6. PubMed ID: 24653034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the ligand binding sites in the translocator protein TSPO using the chimeric bacterial-mammalian constructs.
    Graeber E; Korkhov VM
    Protein Expr Purif; 2019 Dec; 164():105456. PubMed ID: 31326501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the interactions of the 18kDa translocator protein and its ligand PK11195 in planar lipid bilayers.
    Hatty CR; Le Brun AP; Lake V; Clifton LA; Liu GJ; James M; Banati RB
    Biochim Biophys Acta; 2014 Mar; 1838(3):1019-30. PubMed ID: 24374318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the mammalian TSPO/PBR protein.
    Jaremko M; Jaremko Ł; Jaipuria G; Becker S; Zweckstetter M
    Biochem Soc Trans; 2015 Aug; 43(4):566-71. PubMed ID: 26551694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interplay of Cholesterol and Ligand Binding in
    Lai HTT; Giorgetti A; Rossetti G; Nguyen TT; Carloni P; Kranjc A
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33652554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding.
    Murail S; Robert JC; Coïc YM; Neumann JM; Ostuni MA; Yao ZX; Papadopoulos V; Jamin N; Lacapère JJ
    Biochim Biophys Acta; 2008 Jun; 1778(6):1375-81. PubMed ID: 18420025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.
    Lee YS; Siméon FG; Briard E; Pike VW
    ACS Chem Neurosci; 2012 Apr; 3(4):325-35. PubMed ID: 22860199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Integrity of the A147T Polymorph of Mammalian TSPO.
    Jaremko M; Jaremko Ł; Giller K; Becker S; Zweckstetter M
    Chembiochem; 2015 Jul; 16(10):1483-9. PubMed ID: 25974690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mutual and dynamic role of TSPO and ligands in their binding process: An example with PK-11195.
    Rao RM; El Dhaybi I; Cadet F; Etchebest C; Diharce J
    Biochimie; 2024 Mar; ():. PubMed ID: 38494108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unified structural model of the mammalian translocator protein (TSPO).
    Xia Y; Ledwitch K; Kuenze G; Duran A; Li J; Sanders CR; Manning C; Meiler J
    J Biomol NMR; 2019 Jul; 73(6-7):347-364. PubMed ID: 31243635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Backbone and side-chain resonance assignment of the A147T polymorph of mouse TSPO in complex with a high-affinity radioligand.
    Jaremko M; Jaremko Ł; Giller K; Becker S; Zweckstetter M
    Biomol NMR Assign; 2016 Apr; 10(1):79-83. PubMed ID: 26364056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the High-Affinity Drug Ligand Binding Site of Mouse Recombinant TSPO.
    Iatmanen-Harbi S; Senicourt L; Papadopoulos V; Lequin O; Lacapere JJ
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional NMR for membrane proteins: dynamics, ligand binding, and allosteric modulation.
    Oxenoid K; Chou JJ
    Protein Sci; 2016 May; 25(5):959-73. PubMed ID: 26928605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collision Induced Unfolding Classifies Ligands Bound to the Integral Membrane Translocator Protein.
    Fantin SM; Parson KF; Niu S; Liu J; Polasky DA; Dixit SM; Ferguson-Miller SM; Ruotolo BT
    Anal Chem; 2019 Dec; 91(24):15469-15476. PubMed ID: 31743004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine.
    Ostuni MA; Péranzi G; Ducroc RA; Fasseu M; Vidic B; Dumont J; Papadopoulos V; Lacapere JJ
    Biol Cell; 2009 Jul; 101(10):573-86. PubMed ID: 19392661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands.
    Falchi AM; Battetta B; Sanna F; Piludu M; Sogos V; Serra M; Melis M; Putzolu M; Diaz G
    Neuropharmacology; 2007 Aug; 53(2):318-29. PubMed ID: 17631921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism.
    Li F; Liu J; Zheng Y; Garavito RM; Ferguson-Miller S
    Science; 2015 Jan; 347(6221):555-8. PubMed ID: 25635101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.
    Costa B; Da Pozzo E; Giacomelli C; Barresi E; Taliani S; Da Settimo F; Martini C
    Sci Rep; 2016 Jan; 6():18164. PubMed ID: 26750656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.